Drug Topics

JANUARY 30, 2023

As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.

504

504

PharmaVoice

JANUARY 30, 2023

Emerging channels offer new ways to reach key targets and improve campaign ROI.

246

246

Drug Topics

JANUARY 30, 2023

Pfizer Inc. and Moderna Inc. have indicated that they are going to price their shots at between $110 and $130. The shots should still be free to individuals because of rules barring out-of-pocket costs for such vaccinations.

Vaccines 502

Vaccines 502

PharmaVoice

JANUARY 30, 2023

Download the complimentary Guide to Successful Copay Programs that delivers actionable insights to pharma leaders.

246

246

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 30, 2023

Sixteen states have banned a pharmacy benefit management practice that involves not counting the value of drug copay assistance from manufacturers toward patient deductibles.

468

468

PharmaVoice

JANUARY 30, 2023

Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights.

246

246

PharmaVoice

JANUARY 30, 2023

GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.

147

147

STAT

JANUARY 30, 2023

The federal government will audit Medicare Advantage insurers aggressively under a rule finalized Monday, which is expected to result in billions of dollars in overpayments going back toward Medicare’s trust fund and patients over the next decade. However, federal officials watered down one of the auditing policies by giving insurers seven years of immunity from having the samples of their diagnosis coding errors extrapolated to their broader Medicare Advantage membership.

Insurance 145

Insurance Immunization 145

Fierce Healthcare

JANUARY 30, 2023

White House plans to end COVID emergency declarations on May 11 hlandi Mon, 01/30/2023 - 22:10

124

124

STAT

JANUARY 30, 2023

The federal government and health insurance companies have been clashing for more than a decade over how Medicare Advantage plans should be audited and how the well-documented overpayments to those plans should be clawed back. That fight is about to hit an inflection point this week, when Medicare makes a final determination about how aggressively it will probe the industry.

Health Insurance Companies 115

Health Insurance Companies Insurance Documentation 115

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JANUARY 30, 2023

Industry Voices—5 steps to develop an effective 'always-on' patient communication strategy hlandi Mon, 01/30/2023 - 18:17

Communication 122

Communication 122

STAT

JANUARY 30, 2023

SAN FRANCISCO — “Why is it in popular culture, if you want to live forever, you are evil and you want to kill babies on the side?” says Martin Borch Jensen. It’s fast approaching 10 p.m. on the first night of the J.P. Morgan Healthcare Conference , and among a couple stragglers at a dinner for longevity CEOs, scientists, and investors, the conversation has turned from the practical or merely social to the philosophical.

113

113

Fierce Healthcare

JANUARY 30, 2023

Medicare Advantage plans lose out in final RADV audit rule that ditches fee-for-service adjuster rking Mon, 01/30/2023 - 15:36

119

119

STAT

JANUARY 30, 2023

WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how the agency plans to wield new authority to make drug companies enroll post-market clinical trials before granting speedy drug approvals.  That new power is part of reforms to the FDA’s accelerated approval path that Congress recently passed. Accelerated approvals allow the agency to provide fast access to drugs for serious and life-threatening diseases by approving them based on test results

FDA 112

FDA 112

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Store News

JANUARY 30, 2023

4U by Tia, a new haircare brand founded by actress and entrepreneur Tia Mowry, is landing exclusively at Walmart.

112

112

Fierce Healthcare

JANUARY 30, 2023

Commonwealth Fund: US has lower life expectancy but spends most on health compared to other countries rking Mon, 01/30/2023 - 13:32

111

111

Drug Store News

JANUARY 30, 2023

Investments in pharmacy technology and innovation will be a key differentiator for U.S. drug stores wishing to gain an edge over the competition.

111

111

STAT

JANUARY 30, 2023

In a victory for the pharmaceutical industry, a federal appeals court ruled drug companies have the right to limit discounts to hospitals that rely on numerous contract pharmacies as they participate in a U.S. government drug discount program. The decision was made in response to lawsuits that were originally filed by three large drugmakers — Sanofi, Novo Nordisk, and AstraZeneca — that the federal government was unlawfully interpreting key provisions in the controversial 340B drug

Hospitals 110

Hospitals 110

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 30, 2023

Across the world, there are reports of shortages of common antibiotics. Ben Hargreaves examines why these shortages are happening and what is being done in the background to return supply to normal. In many countries across the world, there are shortages of common antibiotics. The problems have been reported across many countries in Europe, in the US, Canada, and Australia.

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

STAT

JANUARY 30, 2023

This month marks the 40th anniversary of the Orphan Drug Act. Since it was signed into law in 1983, the FDA has approved more than 1,100 treatments for rare diseases. The act also created an industry that didn’t exist in the United States before its enactment, enabling the formation of companies to develop and commercialize therapies for rare diseases.

FDA 104

FDA 104

Outsourcing Pharma

JANUARY 30, 2023

The UKâs House of Lords Science and Technology Committee reported the findings from an inquiry into the state of clinical research in the country.

102

102

The Checkup by Singlecare

JANUARY 30, 2023

Your thyroid is a small, butterfly-shaped endocrine gland that sits on top of the trachea, near the bottom of the neck. The thyroid is like the gas pedal to your body: It’s responsible for bodily processes, including metabolism, growth, and brain development. When functioning normally, the thyroid releases a steady amount of thyroid hormones—triiodothyronine (T3) and thyroxine (T4)—into the bloodstream.

Mayo Clinic 98

Mayo Clinic Dosage Immunization Hospitals 98

Outsourcing Pharma

JANUARY 30, 2023

The clinical trial was set up to investigate whether combining opioids with common psychotropic drugs would increase risk of respiratory depression.

FDA 98

FDA 98

STAT

JANUARY 30, 2023

WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing Covid-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first declared. The move to end the national emergency and public health emergency declarations would formally restructure the federal coronavirus response to treat the virus as an endemic threat to public health that can be managed through agencies’ norm

98

98

Fierce Healthcare

JANUARY 30, 2023

Tech startup Paradigm lands $203M to get more patients into clinical research, accelerate drug trials hlandi Mon, 01/30/2023 - 11:51

98

98

STAT

JANUARY 30, 2023

The World Health Organization announced Monday that the Covid-19 pandemic remains a public health emergency, but signaled strongly that it believes it may be able to lift that designation in coming months. The decision to extend the pandemic’s status as a public health emergency of international concern, or PHEIC, was made on the advice of a committee of outside experts who met Friday to deliberate on the issue.

98

98

Fierce Healthcare

JANUARY 30, 2023

Number of people with long COVID appears to be declining, according to CDC data fdiamond Mon, 01/30/2023 - 16:00

98

98

European Pharmaceutical Review

JANUARY 30, 2023

Jaypirca (pirtobrutinib) has been approved by the US Food and Drug Administration (FDA), making it the first and only FDA-approved non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor. It is indicated for adults with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.

FDA 98

FDA 98

Drug Store News

JANUARY 30, 2023

​​​​​​​Customers in Lake Orion and Macomb Township are the first to shop the new Meijer Grocery store concept.

Grocery Stores 98

Grocery Stores 98

STAT

JANUARY 30, 2023

Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine, citing concerns such a move could strain the U.K. National Health Service and public finances. In a letter to Pfizer chief executive officer Albert Bourla, the lawmakers noted the company plans to raise the price of its shot to $110 to $130 a dose in the U.S. and they asked him to confirm during an upcoming call with Wall Street analysts and investors that Pfizer will not take the same step in the U.K.

Vaccines 98

Vaccines 98

Fierce Healthcare

JANUARY 30, 2023

Hospitals faced 'worst financial year since the start of the pandemic' in 2022, Kaufman Hall data show dmuoio Mon, 01/30/2023 - 14:44

Hospitals 98

Hospitals 98

Drug Store News

JANUARY 30, 2023

The new launches include Root Touch Up Color + Volume 2-in-1 Spray, Natural Instincts Bold and Blonde It Up Crystal Glow Toners.

98

98

European Pharmaceutical Review

JANUARY 30, 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), has adopted a positive opinion for a citrate-free high concentration formulation (HCF) of its biosimilar Hyrimoz ® (adalimumab). The authorisation includes all indications covered by the reference medicine Humira ® : rheumatoid arthritis, Crohn’s disease, ulcerative colitis, plaque psoriasis and uveitis.

Packaging 98

Packaging FDA 98